Is there a generic for Bendroflumethiazide; nadolol?

Yes. The FDA Orange Book lists 2 approved generic (ANDA) applications for Bendroflumethiazide; nadolol, referencing the brand CORZIDE. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Bendroflumethiazide; nadolol?

CORZIDE (NDA 018647, KING PHARMS LLC) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Bendroflumethiazide; nadolol are approved?

Bendroflumethiazide; nadolol is approved in the following dosage form: tablet.

FDA Orange Book · active-ingredient family

Bendroflumethiazide; nadolol

Bendroflumethiazide; nadolol is approved as 1 brand and 2 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:CORZIDE · NDA 018647

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · tablet

Product	Applicant	Application	TE	Approved
CORZIDERLD×2	KING PHARMS LLC	NDA 018647	—	May 25, 1983

Generic (ANDA) products (2)

Product	Applicant	Application	TE	Approved
NADOLOL AND BENDROFLUMETHIAZIDE×2	NATCO PHARMA	ANDA 078688	—	Feb 15, 2008
NADOLOL AND BENDROFLUMETHIAZIDE×2	IMPAX LABS	ANDA 077833	—	Mar 30, 2007

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Bendroflumethiazide; nadolol — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo